Cynata has already treated 100 human patients in knee osteoarthritis. It’s going to become 220 by end of next year.
In the process of treating 15 unhealable human wounds in real people with diabetes. Might well be a game changer for wound healing!
Treating 30 seriously sick human patients with gvhd in p2 trial, about to start. Already treated 12 in P1 trial which was a big success.
Soon to be treating kidney transplants of human patients, giving patients a second chance to not rely on immunosuppressants for the rest of their lives.
I know you’re trolling but it really gets on my nerves how you can just say stuff like Cynata only treats rats, when that’s clearly not true. Like it couldn’t be further from the truth. It’s not even ambiguous. It’s just a plain untruth.
There is plenty of legitimate criticism you could make about the company but from a purely clinical perspective hard to say much negative.
CYP Price at posting:
32.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)